6 results on '"Hopfner, F"'
Search Results
2. Mystery surrounding DYT2 dystonia now solved: HPCA mutations identified in DYT2-like family.
- Author
-
Hopfner F and Schneider SA
- Subjects
- Humans, Dystonia genetics, Genes, Recessive genetics, Hippocalcin genetics, Mutation genetics
- Published
- 2015
- Full Text
- View/download PDF
3. The impact of rare variants in FUS in essential tremor.
- Author
-
Hopfner F, Stevanin G, Müller SH, Mundwiller E, Bungeroth M, Durr A, Pendziwiat M, Anheim M, Schneider SA, Tittmann L, Klebe S, Lorenz D, Deuschl G, Brice A, and Kuhlenbäumer G
- Subjects
- Adult, Aged, Aged, 80 and over, DNA Mutational Analysis, Databases, Bibliographic statistics & numerical data, Female, France, Germany, Humans, Male, Middle Aged, Essential Tremor genetics, Mutation genetics, RNA-Binding Protein FUS genetics
- Abstract
Objective: We analyzed the coding region of the Fused in Sarcoma (FUS) gene in familial essential tremor (ET) and reviewed previous studies assessing FUS variants in ET., Background: ET is often a familial disorder with an autosomal dominant inheritance pattern. A potentially causative variant in FUS has been identified in one ET family. Subsequent studies described further putatively causal variants., Methods: We performed DNA sequencing of FUS in 85 unrelated, familial German and French definite ET patients., Results: We did not find novel variants affecting the protein sequence. Seven previously published studies and data from the exome variant server (EVS) showed that rare exonic variants in FUS are not more frequent in ET than in the general population., Conclusions: Our findings provide no evidence for a role of rare genetic variants in the pathogenesis of ET, apart from the initially published FUS mutation segregating in a large ET family., (© 2015 International Parkinson and Movement Disorder Society.)
- Published
- 2015
- Full Text
- View/download PDF
4. Genetics of essential tremor: meta-analysis and review.
- Author
-
Kuhlenbäumer G, Hopfner F, and Deuschl G
- Subjects
- Genome-Wide Association Study, Humans, PubMed statistics & numerical data, Essential Tremor genetics, Genetic Predisposition to Disease genetics, Mutation genetics, Nerve Tissue Proteins genetics
- Abstract
Objective: To provide a comprehensive meta-analysis and review of the clinical and molecular genetics of essential tremor (ET)., Methods: Studies were reviewed from the literature. Linkage studies were analyzed applying criteria used for monogenic disorders. For association studies, allele counts were extracted and allelic association calculated whenever possible. A meta-analysis was performed for genetic markers investigated in more than 3 studies., Results: Linkage studies have shown conclusive results in a single family only for the locus ETM2 (essential tremor monogenetic locus 2, logarithm of odds score [lod] > 3.3). None of the 3 ETM loci has been confirmed independently with a lod score >2.0 in a single family. A mutation in the FUS gene (fused in sarcoma) was found in one ET family by exome sequencing. Two genome-wide association studies demonstrated association between variants in the LINGO1 gene (leucine-rich repeat and Ig domain containing 1) and the SLC1A2 gene (solute carrier family 1 member 2) and ET, respectively. Our meta-analysis confirmed the association of rs9652490 in LINGO1 with ET. Candidate gene mutation analysis and association studies have not identified reproducible associations., Conclusion: Problems of genetic studies of ET are caused by the lack of stringent diagnostic criteria, small sample sizes, lack of biomarkers, a high phenocopy rate, evidence for nonmendelian inheritance, and high locus heterogeneity in presumably monogenic ET. These issues could be resolved by better worldwide cooperation and the use of novel genetic techniques.
- Published
- 2014
- Full Text
- View/download PDF
5. Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.
- Author
-
Hopfner F, Schormair B, Knauf F, Berthele A, Tölle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihöfner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Näbauer M, Kääb S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, and Winkelmann J
- Subjects
- Adult, Base Sequence, DNA Mutational Analysis, Female, Humans, Male, Molecular Sequence Data, Myoclonic Epilepsies, Progressive complications, Myoclonic Epilepsies, Progressive physiopathology, Pedigree, Phenotype, Reverse Transcriptase Polymerase Chain Reaction, Young Adult, Cardiomyopathies genetics, Demyelinating Diseases genetics, Lysosomal Membrane Proteins genetics, Mutation, Myoclonic Epilepsies, Progressive genetics, Receptors, Scavenger genetics
- Abstract
Background: Action myoclonus-renal failure syndrome is a hereditary form of progressive myoclonus epilepsy associated with renal failure. It is considered to be an autosomal-recessive disease related to loss-of-function mutations in SCARB2. We studied a German AMRF family, additionally showing signs of demyelinating polyneuropathy and dilated cardiomyopathy. To test the hypothesis whether isolated appearance of individual AMRF syndrome features could be related to heterozygote SCARB2 mutations, we screened for SCARB2 mutations in unrelated patients showing isolated AMRF features., Methods: In the AMRF family all exons of SCARB2 were analyzed by Sanger sequencing. The mutation screening of unrelated patients with isolated AMRF features affected by either epilepsy (n = 103, progressive myoclonus epilepsy or generalized epilepsy), demyelinating polyneuropathy (n = 103), renal failure (n = 192) or dilated cardiomyopathy (n = 85) was performed as high resolution melting curve analysis of the SCARB2 exons., Results: A novel homozygous 1 bp deletion (c.111delC) in SCARB2 was found by sequencing three affected homozygous siblings of the affected family. A heterozygous sister showed generalized seizures and reduction of nerve conduction velocity in her legs. No mutations were found in the epilepsy, renal failure or dilated cardiomyopathy samples. In the polyneuropathy sample two individuals with demyelinating disease were found to be carriers of a SCARB2 frameshift mutation (c.666delCCTTA)., Conclusions: Our findings indicate that demyelinating polyneuropathy and dilated cardiomyopathy are part of the action myoclonus-renal failure syndrome. Moreover, they raise the possibility that in rare cases heterozygous SCARB2 mutations may be associated with PNP features.
- Published
- 2011
- Full Text
- View/download PDF
6. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis.
- Author
-
Duering M, Karpinska A, Rosner S, Hopfner F, Zechmeister M, Peters N, Kremmer E, Haffner C, Giese A, Dichgans M, and Opherk C
- Subjects
- Cross-Linking Reagents pharmacology, Electrophoresis, Polyacrylamide Gel, Epidermal Growth Factor metabolism, HEK293 Cells, Humans, Maleimides metabolism, Mutant Proteins chemistry, Mutant Proteins metabolism, Protein Multimerization drug effects, Protein Structure, Quaternary, Receptor, Notch3, Recombinant Proteins metabolism, Reproducibility of Results, Sulfhydryl Reagents metabolism, Thrombospondins metabolism, CADASIL genetics, Mutation genetics, Receptors, Notch chemistry, Receptors, Notch metabolism
- Abstract
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common monogenic cause of stroke and vascular dementia. Accumulation and deposition of the NOTCH3 (N3) extracellular domain in small blood vessels has been recognized as a central pathological feature of the disease. Recent experiments suggested enhanced formation of higher order multimers for mutant N3 compared with wild-type (WT). However, the mechanisms and consequences of N3 multimerization are still poorly understood, in part because of the lack of an appropriate in vitro aggregation assay. We therefore developed and validated a robust assay based on recombinant N3 fragments purified from cell culture supernatants. Using single-molecule analysis techniques such as scanning for intensely fluorescent targets and single-particle fluorescence resonance energy transfer, we show that spontaneous aggregation is limited to CADASIL-mutant N3, recapitulating a central aspect of CADASIL pathology in vitro. N3 aggregation requires no co-factor and is facilitated by sulfhydryl crosslinking. Although WT N3 does not exhibit multimerization itself, it can participate in aggregates of mutant N3. Furthermore, we demonstrate that thrombospondin-2, a known interaction partner of N3, co-aggregates with mutant N3. Sequestration of WT N3 and other proteins into aggregates represents a potentially important disease mechanism. These findings in combination with a new assay for single-molecule aggregation analysis provide novel opportunities for the development of therapeutic strategies.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.